Attilla Ting

637 total citations
17 papers, 467 citations indexed

About

Attilla Ting is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Attilla Ting has authored 17 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Attilla Ting's work include DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Attilla Ting is often cited by papers focused on DNA Repair Mechanisms (5 papers), Cancer therapeutics and mechanisms (4 papers) and Protease and Inhibitor Mechanisms (4 papers). Attilla Ting collaborates with scholars based in United Kingdom, Germany and Poland. Attilla Ting's co-authors include S. Gerhardt, Frederick W. Goldberg, Gillian M. Lamont, David Hargreaves, David T. Beattie, Richard A. Pauptit, Julia Bárdos, Eileen McCall, Bernard T. Golding and M. Raymond V. Finlay and has published in prestigious journals such as Journal of Molecular Biology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Attilla Ting

17 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Attilla Ting United Kingdom 13 267 164 100 92 58 17 467
Michael R. Gehring United States 10 317 1.2× 125 0.8× 79 0.8× 90 1.0× 69 1.2× 13 446
André Richters Germany 17 480 1.8× 144 0.9× 212 2.1× 111 1.2× 65 1.1× 24 776
Laura L. Rokosz United States 14 379 1.4× 227 1.4× 167 1.7× 178 1.9× 43 0.7× 26 660
Alan G. Olivero United States 13 312 1.2× 89 0.5× 200 2.0× 56 0.6× 49 0.8× 26 618
Grace E. Munie United States 14 212 0.8× 204 1.2× 95 0.9× 222 2.4× 23 0.4× 17 478
Mingsong Shi China 14 261 1.0× 114 0.7× 131 1.3× 32 0.3× 30 0.5× 58 470
Marc R. Arnone United States 7 474 1.8× 201 1.2× 113 1.1× 55 0.6× 122 2.1× 7 620
Zhonghui Lu United States 9 169 0.6× 101 0.6× 186 1.9× 58 0.6× 40 0.7× 12 370
Christophe Henry France 12 160 0.6× 158 1.0× 100 1.0× 39 0.4× 24 0.4× 25 459
Carolyn A. Weigelt United States 14 255 1.0× 169 1.0× 147 1.5× 26 0.3× 41 0.7× 25 520

Countries citing papers authored by Attilla Ting

Since Specialization
Citations

This map shows the geographic impact of Attilla Ting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attilla Ting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attilla Ting more than expected).

Fields of papers citing papers by Attilla Ting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attilla Ting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attilla Ting. The network helps show where Attilla Ting may publish in the future.

Co-authorship network of co-authors of Attilla Ting

This figure shows the co-authorship network connecting the top 25 collaborators of Attilla Ting. A scholar is included among the top collaborators of Attilla Ting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attilla Ting. Attilla Ting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Goldberg, Frederick W., Attilla Ting, David T. Beattie, et al.. (2022). Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8H-purin-8-one Inhibitors of DNA-PK. ACS Medicinal Chemistry Letters. 13(8). 1295–1301. 7 indexed citations
2.
Goldberg, Frederick W., Jason G. Kettle, Gillian M. Lamont, et al.. (2022). Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. Journal of Medicinal Chemistry. 66(1). 384–397. 38 indexed citations
3.
Goldberg, Frederick W., M. Raymond V. Finlay, Attilla Ting, et al.. (2019). The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor. Journal of Medicinal Chemistry. 63(7). 3461–3471. 66 indexed citations
4.
Goldberg, Frederick W., Elaine Cadogan, David A. Beattie, et al.. (2019). Abstract DDT01-02: Discovery and first structural disclosure of AZD7648: A potent and selective DNA-PK inhibitor. DDT01–2. 1 indexed citations
5.
Goldberg, Frederick W., Elaine Cadogan, David T. Beattie, et al.. (2019). Abstract DDT01-02: Discovery and first structural disclosure of AZD7648: A potent and selective DNA-PK inhibitor. Cancer Research. 79(13_Supplement). DDT01–2. 1 indexed citations
6.
Krämer, Christian, Attilla Ting, Hao Zheng, et al.. (2017). Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA). Journal of Medicinal Chemistry. 61(8). 3277–3292. 67 indexed citations
7.
O’Connor, Lenka Oplustil, Stuart L. Rulten, Aaron Cranston, et al.. (2016). The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models. Cancer Research. 76(20). 6084–6094. 60 indexed citations
8.
Cano, Céline, Chris Bailey, Julia Bárdos, et al.. (2013). 1-Substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity. Journal of Medicinal Chemistry. 56(16). 6386–6401. 42 indexed citations
9.
Jones, Gavin O., Julia Bárdos, Bernard T. Golding, et al.. (2012). Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives. Organic & Biomolecular Chemistry. 10(33). 6747–6747. 20 indexed citations
10.
Savi, Chris De, Andrew R. Pape, John G. Cumming, et al.. (2011). The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry Letters. 21(5). 1376–1381. 18 indexed citations
11.
Savi, Chris De, Andrew R. Pape, John G. Cumming, et al.. (2011). Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry Letters. 21(11). 3301–3306. 13 indexed citations
12.
Savi, Chris De, Andrew Morley, Galith Karoutchi, et al.. (2011). Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2. Bioorganic & Medicinal Chemistry Letters. 22(1). 271–277. 12 indexed citations
13.
Savi, Chris De, Andrew Morley, Attilla Ting, et al.. (2011). Selective non zinc binding inhibitors of MMP13. Bioorganic & Medicinal Chemistry Letters. 21(14). 4215–4219. 18 indexed citations
14.
Bárdos, Julia, M. Raymond V. Finlay, Bernard T. Golding, et al.. (2010). DNA-dependent protein kinase (DNA-PK) inhibitors: Structure–activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domain. Bioorganic & Medicinal Chemistry Letters. 21(3). 966–970. 18 indexed citations
15.
Elliot, David J., Philip A. MacFaul, Andrew Morley, et al.. (2009). Novel inhibitors of the αvβ3 integrin—lead identification strategy. Bioorganic & Medicinal Chemistry Letters. 19(16). 4832–4835. 12 indexed citations
16.
Gerhardt, S., Eileen McCall, Liz Flavell, et al.. (2007). Crystal Structures of Human ADAMTS-1 Reveal a Conserved Catalytic Domain and a Disintegrin-like Domain with a Fold Homologous to Cysteine-Rich Domains. Journal of Molecular Biology. 373(4). 891–902. 68 indexed citations
17.
Ting, Attilla, et al.. (2000). Expert System Assisted Pharmacophore Identification. Journal of Chemical Information and Computer Sciences. 40(2). 347–353. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael R. Gehring Breakdown of academic impact, for papers by André Richters Breakdown of academic impact, for papers by Laura L. Rokosz Breakdown of academic impact, for papers by Alan G. Olivero Breakdown of academic impact, for papers by Grace E. Munie Breakdown of academic impact, for papers by Mingsong Shi Breakdown of academic impact, for papers by Marc R. Arnone Breakdown of academic impact, for papers by Zhonghui Lu Breakdown of academic impact, for papers by Christophe Henry Breakdown of academic impact, for papers by Carolyn A. Weigelt
Rankless by CCL
2026